| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/29/2004 | US20040018605 Anticancer agents; autoimmune diseases; central nervous system disorders; polymerase chain reactions |
| 01/29/2004 | US20040018594 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 01/29/2004 | US20040018593 Anti-RELP fusion antibodies, compositions, methods and uses |
| 01/29/2004 | US20040018587 Nanostructures containing antibody assembly units |
| 01/29/2004 | US20040018577 Multiple hybrid immunoassay |
| 01/29/2004 | US20040018574 Molecular differences between species of the M. tuberculosis complex |
| 01/29/2004 | US20040018573 Production of functional antibodies in filamentous fungi |
| 01/29/2004 | US20040018571 PSCA: prostate stem cell antigen and uses thereof |
| 01/29/2004 | US20040018569 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection |
| 01/29/2004 | US20040018568 Reduce immunology response; genetic engineered polypeptide |
| 01/29/2004 | US20040018557 High speed elimination of immunoglobulins from human body |
| 01/29/2004 | US20040018542 Phosphodiesterase enzymes |
| 01/29/2004 | US20040018514 Nucleotide sequence derived from Listeria inocua |
| 01/29/2004 | US20040018508 Surrogate antibodies and methods of preparation and use thereof |
| 01/29/2004 | US20040018203 Connector molecule attaching a targeting molecule to an effector molecule is conjugated to polyethylene glycol (peg) molecules |
| 01/29/2004 | US20040018202 Reverse a symptom including intravascular volume contraction, vasoconstriction and exaggerated myocardial function |
| 01/29/2004 | US20040018201 Method for controlling preeclampsia and eclampsia |
| 01/29/2004 | US20040018200 >/= 15 mg/ml of an antibody, or a fragment that immunospecifically binds to a respiratory syncytial virus antigen and histidine in an aqueous carrier |
| 01/29/2004 | US20040018198 Antibodies against carbonic anydrase IX (CA IX) tumor antigen |
| 01/29/2004 | US20040018197 Administering an antibody to colipase |
| 01/29/2004 | US20040018196 Proteins and nucleic acids encoding same |
| 01/29/2004 | US20040018195 Antidiabetic complemetary determining region protein that binds epitopes containing specific amino acid sequences |
| 01/29/2004 | US20040018194 Administering proteins that bind to CD30, or compete with monoclonal antibodies AC10 or HeFi-1 for binding to CD30, and exert a cytostatic or cytotoxic effect on Hodgkin's disease cells in the absence of effector cells or complement |
| 01/29/2004 | US20040018191 Neutralizing human anti-IGFR antibody |
| 01/29/2004 | US20040018190 Drugs and foods improving the quality of life and process for producing the same |
| 01/29/2004 | US20040018189 Nucleic acid and corresponding protein entitled 121P2A3 useful in treatment and detection of cancer |
| 01/29/2004 | US20040018181 MUC1 interference RNA compositions and methods derived therefrom |
| 01/29/2004 | US20040018173 Composition and method for the treatment and prevention of metastatic disorders |
| 01/29/2004 | US20040018171 Biochemical conjugates comprising tumor necrosis factor or interferons and ligands of CD antigen receptors, used as anticarcinogenic agents |
| 01/29/2004 | US20040018152 Biologically active molecules encapsulated in self-assembling, diketopiperazine microspheres, TECHNOSPHEREs tm ) and methods for making and administering such compositions are described herein. The compositions can be used to immunize individuals |
| 01/29/2004 | CA2803741A1 Treatment of psoriasis with human anti-tnf alpha antibody |
| 01/29/2004 | CA2496253A1 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 01/29/2004 | CA2493768A1 Embryonic stem cell markers and uses thereof |
| 01/29/2004 | CA2493679A1 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 01/29/2004 | CA2493572A1 Methods and compositions for activating or inhibiting vegf-d and vegf-c |
| 01/29/2004 | CA2493254A1 Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof |
| 01/29/2004 | CA2493067A1 Treatment of tnf.alpha. related disorders |
| 01/29/2004 | CA2492996A1 Single chain antibody and utilization thereof |
| 01/29/2004 | CA2492498A1 Flea and tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 01/29/2004 | CA2492377A1 Recombinant production of mixtures of antibodies |
| 01/29/2004 | CA2467691A1 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 01/28/2004 | EP1384726A2 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 01/28/2004 | EP1384488A2 Method and kit for imaging organs and tissues, using labelled antibodies |
| 01/28/2004 | EP1384487A1 Drugs containing genetically modified antibody against ganglioside gd3 |
| 01/28/2004 | EP1384075A1 Methods of detecting early renal disease in animals |
| 01/28/2004 | EP1383931A1 Nucleic acid vaccines for prevention of flavivirus infection |
| 01/28/2004 | EP1383927A2 New polynucleotides and polypeptides of the erythropoietin gene |
| 01/28/2004 | EP1383922A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer |
| 01/28/2004 | EP1383919A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 01/28/2004 | EP1383918A2 An animal model for enteric pathogens |
| 01/28/2004 | EP1383895A2 Polynucleotides and polypeptides of the ifnalpha-5 gene |
| 01/28/2004 | EP1383893A2 Proteins and nucleic acids encoding same |
| 01/28/2004 | EP1383892A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/28/2004 | EP1383884A2 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon |
| 01/28/2004 | EP1383883A2 Asthma-associated snps around microsatellite marker d2s308 and identification of human prolyl-oligopeptidase-dpp10 |
| 01/28/2004 | EP1383878A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 01/28/2004 | EP1383802A2 Anti-muc-1 single chain antibodies for tumor targeting |
| 01/28/2004 | EP1383801A1 Antibodies against cancer |
| 01/28/2004 | EP1383800A1 RECOMBINANT ANTIBODIES COEXPRESSED WITH GnTIII |
| 01/28/2004 | EP1383799A1 Probes, systems and methods for drug discovery |
| 01/28/2004 | EP1383798A2 Transporters and ion channels |
| 01/28/2004 | EP1383790A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr protein, and uses thereof |
| 01/28/2004 | EP1383789A2 Proteins associated with cell growth, differentiation, and death |
| 01/28/2004 | EP1383785A2 Recombinant tumor specific antibody and use thereof |
| 01/28/2004 | EP1383784A1 A hepatitis b virus surface antigen mutant and methods of detection thereof |
| 01/28/2004 | EP1383783A2 Leinamycin biosynthesis gene cluster and its components and their uses |
| 01/28/2004 | EP1383544A1 Anti-cd19 immunotoxins |
| 01/28/2004 | EP1383532A2 Combination therapy |
| 01/28/2004 | EP1383528A2 Epitope sequences |
| 01/28/2004 | EP1383526A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/28/2004 | EP0968291B1 Antibody fragment-polymer conjugates |
| 01/28/2004 | EP0914345B1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 01/28/2004 | EP0724597B1 Ks-laminin and methods of use |
| 01/28/2004 | CN1471587A Gene markers for lung cancer |
| 01/28/2004 | CN1471539A Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies |
| 01/28/2004 | CN1471406A Preventives or remedies for psoriasis containing as the active ingredient IL-6 antagonist |
| 01/28/2004 | CN1470635A Polypeptide-human protein tyrosine phosphatase 10 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470530A Humanmachine tumour monoclonal antibody, and its preparing method and use |
| 01/28/2004 | CN1470527A Polypeptide-human calcium ion regulatory secretory action protein 48 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470526A Polypeptide-human muscle BOP protein 41 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470525A Polypeptide-human SEH protein 29 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470524A Polypeptide-human transcriptional elongation factor IIS51 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470523A Polypeptide-zinc finger protein 64 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470522A Polypeptide-XRN-100 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470521A Polypeptide-mitochondrial carrier 12 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1470520A Polypeptide-zine finger protein 40 and polynucleotide encoding this polypeptide |
| 01/28/2004 | CN1136008C Method for detection of i (legioneela) bacteria employing purified entigen-specific antibodies |
| 01/27/2004 | US6683210 Human t-cell leukemia/lymphoma virus, human immunodeficiency virus, and lymphadenopathy associated virus treatment |
| 01/27/2004 | US6683171 Contacting fkhsf specific nucleic acid probe under high stringency hybridizing conditions with at least one nucleic acid molecule from biological sample, detecting formation of hybrid, indicating presence of fkhsf nucleic acid molecule |
| 01/27/2004 | US6683160 Antibodies specific for Fkhsf gene products |
| 01/27/2004 | US6683158 Alpha-subunit of the Mac-1 leukocyte adhesion receptor |
| 01/27/2004 | US6683155 Purified and isolated polypeptide comprising specified amino acid sequence; regulating degradation of extracellular matrix |
| 01/27/2004 | US6683053 Insulin-like growth factor agonist molecules |
| 01/27/2004 | US6683046 Purification and characterization of cytotoxic lymphocyte maturation factor and monoclonal antibodies thereto |
| 01/27/2004 | US6682928 Cell is transformed to express on its surface a component which binds to an fc receptor of an effector cell used as a vehicle to increase an cell lysis and phagocytosis against an antigen associated with the cell |
| 01/27/2004 | US6682917 Rate-limiting enzyme, which converts ribonucleotides to their corresponding deoxyribonucleotides and supplies them for purposes of dna synthesis; drug comprising protein; kit for screening for modulators of protein activity |
| 01/27/2004 | US6682902 Human extracellular matrix polypeptides; polynucleotides; expression vectors; host cells; medical diagnosis; prostate cancer; detection of metastasis |
| 01/27/2004 | US6682901 Detecting cancer in humans; obtain cells, incubate with cadherins, monitor binding |
| 01/27/2004 | US6682896 Isolated polyclonal antibody having neutralizing binding affinity for said peptides; diagnostic or prognostic assay where patient receiving ifn-beta therapy can be assessed for production of ifn-beta neutralizing antibodies |
| 01/27/2004 | US6682737 Monoclonal antibody having the same or overlapping epitope binding specificity as that of 3e2 secreted by hybridoma atcc hb 12075 |